Titre : Séquences d'acides nucléiques régulatrices

Séquences d'acides nucléiques régulatrices : Questions médicales fréquentes

Termes MeSH sélectionnés :

Data Accuracy
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Séquences d'acides nucléiques régulatrices : Questions médicales les plus fréquentes", "headline": "Séquences d'acides nucléiques régulatrices : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Séquences d'acides nucléiques régulatrices : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-21", "dateModified": "2025-04-15", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Séquences d'acides nucléiques régulatrices" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Structures génétiques", "url": "https://questionsmedicales.fr/mesh/D040342", "about": { "@type": "MedicalCondition", "name": "Structures génétiques", "code": { "@type": "MedicalCode", "code": "D040342", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Réseaux de régulation génique", "alternateName": "Gene Regulatory Networks", "url": "https://questionsmedicales.fr/mesh/D053263", "about": { "@type": "MedicalCondition", "name": "Réseaux de régulation génique", "code": { "@type": "MedicalCode", "code": "D053263", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.080.689.360" } } }, { "@type": "MedicalWebPage", "name": "Séquences régulatrices de l'acide ribonucléique", "alternateName": "Regulatory Sequences, Ribonucleic Acid", "url": "https://questionsmedicales.fr/mesh/D038621", "about": { "@type": "MedicalCondition", "name": "Séquences régulatrices de l'acide ribonucléique", "code": { "@type": "MedicalCode", "code": "D038621", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.080.689.687" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Sites internes d'entrée des ribosomes", "alternateName": "Internal Ribosome Entry Sites", "url": "https://questionsmedicales.fr/mesh/D000067556", "about": { "@type": "MedicalCondition", "name": "Sites internes d'entrée des ribosomes", "code": { "@type": "MedicalCode", "code": "D000067556", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.080.689.687.093" } } }, { "@type": "MedicalWebPage", "name": "Riborégulateur", "alternateName": "Riboswitch", "url": "https://questionsmedicales.fr/mesh/D058928", "about": { "@type": "MedicalCondition", "name": "Riborégulateur", "code": { "@type": "MedicalCode", "code": "D058928", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.080.689.687.124" } } } ] }, { "@type": "MedicalWebPage", "name": "Séquence d'encapsidation virale", "alternateName": "Viral Packaging Sequence", "url": "https://questionsmedicales.fr/mesh/D000086502", "about": { "@type": "MedicalCondition", "name": "Séquence d'encapsidation virale", "code": { "@type": "MedicalCode", "code": "D000086502", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.080.689.905" } } } ], "about": { "@type": "MedicalCondition", "name": "Séquences d'acides nucléiques régulatrices", "alternateName": "Regulatory Sequences, Nucleic Acid", "code": { "@type": "MedicalCode", "code": "D012045", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Chad A Mirkin", "url": "https://questionsmedicales.fr/author/Chad%20A%20Mirkin", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Xiaolei Zuo", "url": "https://questionsmedicales.fr/author/Xiaolei%20Zuo", "affiliation": { "@type": "Organization", "name": "Institute of Molecular Medicine, Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127 China." } }, { "@type": "Person", "name": "Qian Li", "url": "https://questionsmedicales.fr/author/Qian%20Li", "affiliation": { "@type": "Organization", "name": "School of Chemistry and Chemical Engineering, Frontiers Science Center for Transformative Molecules, Institute of Translational Medicine, Shanghai Jiao Tong University, Shanghai, 200240 China." } }, { "@type": "Person", "name": "Chunhai Fan", "url": "https://questionsmedicales.fr/author/Chunhai%20Fan", "affiliation": { "@type": "Organization", "name": "Institute of Molecular Medicine, Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127 China." } }, { "@type": "Person", "name": "Hanadi F Sleiman", "url": "https://questionsmedicales.fr/author/Hanadi%20F%20Sleiman", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, McGill University, 801 Sherbrooke St W, Montréal, QC H3A 08B, Canada." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Accuracy, potential, and limitations of probabilistic record linkage in identifying deaths by gender identity and sexual orientation in the state of Rio De Janeiro, Brazil.", "datePublished": "2024-06-01", "url": "https://questionsmedicales.fr/article/38824562", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12889-024-19002-x" } }, { "@type": "ScholarlyArticle", "name": "Evaluation of data quality in the Swedish National Penile Cancer Register.", "datePublished": "2024-10-02", "url": "https://questionsmedicales.fr/article/39356203", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2340/sju.v59.42029" } }, { "@type": "ScholarlyArticle", "name": "The National Swedish Lymphoma Register - a systematic validation of data quality.", "datePublished": "2024-07-10", "url": "https://questionsmedicales.fr/article/38988133", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2340/1651-226X.2024.40431" } }, { "@type": "ScholarlyArticle", "name": "Data Quality in Health Care: Main Concepts and Assessment Methodologies.", "datePublished": "2023-01-30", "url": "https://questionsmedicales.fr/article/36716776", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1055/s-0043-1761500" } }, { "@type": "ScholarlyArticle", "name": "Data quality assessment in emergency medical services: an objective approach.", "datePublished": "2023-01-30", "url": "https://questionsmedicales.fr/article/36717771", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12873-023-00781-2" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes génétiques", "item": "https://questionsmedicales.fr/mesh/D055614" }, { "@type": "ListItem", "position": 3, "name": "Structures génétiques", "item": "https://questionsmedicales.fr/mesh/D040342" }, { "@type": "ListItem", "position": 4, "name": "Séquences d'acides nucléiques régulatrices", "item": "https://questionsmedicales.fr/mesh/D012045" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Séquences d'acides nucléiques régulatrices - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Séquences d'acides nucléiques régulatrices", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Séquences d'acides nucléiques régulatrices", "description": "Comment identifier une séquence régulatrice ?\nQuels tests sont utilisés pour analyser les séquences régulatrices ?\nPeut-on détecter des mutations dans ces séquences ?\nQuels marqueurs sont associés aux séquences régulatrices ?\nComment évaluer l'activité d'une séquence régulatrice ?", "url": "https://questionsmedicales.fr/mesh/D012045?mesh_terms=Data+Accuracy&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Séquences d'acides nucléiques régulatrices", "description": "Quels symptômes sont liés à des anomalies régulatrices ?\nLes séquences régulatrices affectent-elles le développement ?\nPeut-on observer des symptômes neurologiques ?\nLes troubles hormonaux sont-ils liés à ces séquences ?\nY a-t-il des symptômes immunologiques associés ?", "url": "https://questionsmedicales.fr/mesh/D012045?mesh_terms=Data+Accuracy&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Séquences d'acides nucléiques régulatrices", "description": "Comment prévenir les maladies liées aux séquences régulatrices ?\nLes conseils génétiques sont-ils utiles ?\nPeut-on éviter les mutations par des choix de vie ?\nLes vaccinations jouent-elles un rôle ?\nY a-t-il des programmes de sensibilisation ?", "url": "https://questionsmedicales.fr/mesh/D012045?mesh_terms=Data+Accuracy&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Séquences d'acides nucléiques régulatrices", "description": "Quels traitements ciblent les séquences régulatrices ?\nPeut-on corriger des mutations régulatrices ?\nLes traitements sont-ils personnalisés ?\nQuels sont les défis des traitements ?\nY a-t-il des essais cliniques en cours ?", "url": "https://questionsmedicales.fr/mesh/D012045?mesh_terms=Data+Accuracy&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Séquences d'acides nucléiques régulatrices", "description": "Quelles complications peuvent survenir ?\nLes complications sont-elles héréditaires ?\nComment les complications sont-elles gérées ?\nY a-t-il des risques de récidive ?\nLes complications affectent-elles la qualité de vie ?", "url": "https://questionsmedicales.fr/mesh/D012045?mesh_terms=Data+Accuracy&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Séquences d'acides nucléiques régulatrices", "description": "Quels sont les facteurs de risque génétiques ?\nL'environnement influence-t-il ces séquences ?\nLe mode de vie joue-t-il un rôle ?\nLes infections sont-elles un facteur de risque ?\nY a-t-il des facteurs de risque liés à l'âge ?", "url": "https://questionsmedicales.fr/mesh/D012045?mesh_terms=Data+Accuracy&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier une séquence régulatrice ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'identification se fait par des techniques comme la PCR et le séquençage." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour analyser les séquences régulatrices ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests comme l'empreinte génétique et l'analyse de l'expression génique sont utilisés." } }, { "@type": "Question", "name": "Peut-on détecter des mutations dans ces séquences ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des mutations peuvent être détectées par séquençage ciblé ou NGS." } }, { "@type": "Question", "name": "Quels marqueurs sont associés aux séquences régulatrices ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les marqueurs épigénétiques comme la méthylation de l'ADN sont souvent associés." } }, { "@type": "Question", "name": "Comment évaluer l'activité d'une séquence régulatrice ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'activité peut être évaluée par des essais de reporter génique." } }, { "@type": "Question", "name": "Quels symptômes sont liés à des anomalies régulatrices ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies peuvent entraîner des maladies génétiques, des cancers ou des troubles métaboliques." } }, { "@type": "Question", "name": "Les séquences régulatrices affectent-elles le développement ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles jouent un rôle crucial dans le développement embryonnaire et cellulaire." } }, { "@type": "Question", "name": "Peut-on observer des symptômes neurologiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Certaines mutations régulatrices peuvent être liées à des troubles neurologiques." } }, { "@type": "Question", "name": "Les troubles hormonaux sont-ils liés à ces séquences ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des séquences régulatrices peuvent influencer la régulation hormonale." } }, { "@type": "Question", "name": "Y a-t-il des symptômes immunologiques associés ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies peuvent entraîner des dysfonctionnements du système immunitaire." } }, { "@type": "Question", "name": "Comment prévenir les maladies liées aux séquences régulatrices ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par le dépistage génétique et la sensibilisation aux facteurs de risque." } }, { "@type": "Question", "name": "Les conseils génétiques sont-ils utiles ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils aident à évaluer le risque et à prendre des décisions éclairées." } }, { "@type": "Question", "name": "Peut-on éviter les mutations par des choix de vie ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Certains choix de vie, comme l'alimentation et l'exercice, peuvent réduire les risques." } }, { "@type": "Question", "name": "Les vaccinations jouent-elles un rôle ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Certaines vaccinations peuvent prévenir des infections qui influencent l'expression génique." } }, { "@type": "Question", "name": "Y a-t-il des programmes de sensibilisation ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des programmes éducatifs sensibilisent aux maladies génétiques et à leur prévention." } }, { "@type": "Question", "name": "Quels traitements ciblent les séquences régulatrices ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies géniques et des médicaments ciblant des voies spécifiques sont en développement." } }, { "@type": "Question", "name": "Peut-on corriger des mutations régulatrices ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des techniques comme CRISPR permettent de corriger certaines mutations." } }, { "@type": "Question", "name": "Les traitements sont-ils personnalisés ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la médecine personnalisée adapte les traitements selon le profil génétique." } }, { "@type": "Question", "name": "Quels sont les défis des traitements ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les défis incluent la spécificité, l'efficacité et les effets secondaires potentiels." } }, { "@type": "Question", "name": "Y a-t-il des essais cliniques en cours ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, de nombreux essais cliniques explorent des thérapies ciblant ces séquences." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des cancers, des troubles métaboliques et des maladies auto-immunes." } }, { "@type": "Question", "name": "Les complications sont-elles héréditaires ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être héréditaires, liées à des mutations dans les séquences régulatrices." } }, { "@type": "Question", "name": "Comment les complications sont-elles gérées ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "La gestion implique un suivi médical régulier et des traitements adaptés." } }, { "@type": "Question", "name": "Y a-t-il des risques de récidive ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains troubles peuvent avoir un risque de récidive, nécessitant une surveillance." } }, { "@type": "Question", "name": "Les complications affectent-elles la qualité de vie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent significativement impacter la qualité de vie des patients." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque génétiques ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des antécédents familiaux de maladies génétiques augmentent le risque." } }, { "@type": "Question", "name": "L'environnement influence-t-il ces séquences ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des facteurs environnementaux comme les toxines peuvent affecter l'expression génique." } }, { "@type": "Question", "name": "Le mode de vie joue-t-il un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des habitudes comme le tabagisme et l'alimentation peuvent influencer le risque." } }, { "@type": "Question", "name": "Les infections sont-elles un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections peuvent déclencher des modifications dans les séquences régulatrices." } }, { "@type": "Question", "name": "Y a-t-il des facteurs de risque liés à l'âge ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de maladies génétiques augmente avec l'âge." } } ] } ] }

Sources (10000 au total)

Accuracy, potential, and limitations of probabilistic record linkage in identifying deaths by gender identity and sexual orientation in the state of Rio De Janeiro, Brazil.

Globally, the counting of deaths based on gender identity and sexual orientation has been a challenge for health systems. In most cases, non-governmental organizations have dedicated themselves to thi... This study evaluated the accuracy of the probabilistic record linkage to obtain information on deaths according to gender and sexual orientation. Data from two information systems were used from June ... The best data blocking strategy was established through logical blocks with the first and last names, birthdate, and mother's name in the pairing strategy. With a population base of 80,178 records, 15... With the identification of possible strategies for determining probabilistic data relationships, the retrieval of information on mortality according to sexual and gender markers has become feasible. B...

Evaluation of data quality in the Swedish National Penile Cancer Register.

The National Penile Cancer Register (NPECR) in Sweden was initiated in year 2000 and currently contains more than 3,900 men diagnosed with penile cancer. The aim of this study was to evaluate data qua... Completeness was assessed by cross-linkage to the Swedish Cancer Register. Timeliness, defined as time from date of diagnosis to date of reporting in the NPECR, was calculated. Comparability was evalu... Completeness was high (93%). Timeliness was in median 4.6 (Inter Quartile Range 2.6-8.8) months. Comparability was good with coding routines and the registration forms were in compliance with current ... Data quality in the Swedish NPECR is generally high with respect to completeness, timeliness, comparability, and validity. Hence, the NPECR represents a reliable data source for monitoring the quality...

The National Swedish Lymphoma Register - a systematic validation of data quality.

The Swedish Lymphoma Register (SLR) was initiated in the year 2000 with the aim to monitor quality of care in diagnostics, treatment and outcome of all lymphomas diagnosed nationally among adults. Her... We evaluated timeliness and completeness of register records among patients diagnosed with lymphoma in the SLR (n = 16,905) compared with the National Cancer Register for the period 2013-2020. Compara... Completeness and accuracy are high in the SLR, while timeliness could be improved. Finetuning of variable registration guided by this validation can further improve reliability of register reports and...

Data Quality in Health Care: Main Concepts and Assessment Methodologies.

In the health care environment, a huge volume of data is produced on a daily basis. However, the processes of collecting, storing, sharing, analyzing, and reporting health data usually face with numer... The purpose of this article is to provide an insight into the data quality definitions, dimensions, and assessment methodologies.... In this article, a scoping literature review approach was used to describe and summarize the main concepts related to data quality and data quality assessment methodologies. Search terms were selected... In total, 23 papers were included in the study. According to the results, data quality dimensions were various and different methodologies were used to assess them. Most studies used quantitative meth... In health care, high-quality data not only are important for patient care, but also are vital for improving quality of health care services and better decision making. Therefore, using technical and n...

Data quality assessment in emergency medical services: an objective approach.

In emergency medical services, high quality data are of great importance for patient care. Due to the unique nature of this type of services, the purpose of this study was to assess data quality in em... This was a retrospective quantitative study conducted in 2019. The research sample included the emergency medical records of patients who referred to three emergency departments by the pre-hospital em... Data completeness in the triage form, pre-hospital emergency care form, and emergency medical records was 52.3%, 70% and 57.3%, respectively. Regarding data accuracy, most of the data elements were co... Data quality in emergency medical services was not satisfactory and there were some weaknesses in the documentation processes. The results of this study can inform the clinical and administrative staf...

Undernotification and underreporting of tuberculosis in Zambia: a national data quality assessment.

Despite national implementation of several high impact interventions and innovations to bolster tuberculosis (TB) detection and improve quality of TB services in Zambia, notifications have been declin... The NTLP conducted a retrospective DQA of health facilities in high burden districts in all ten Zambian provinces. Multiple routine programmatic data sources were triangulated through a multi-step ver... Overall, 265 health facilities across 55 districts were assessed from which 28,402 TB patients were identified; 94.5% of TB patients were ≥ 15 years old, 65.1% were male, 52.0% were HIV-positive, and ... The findings from Zambia's first countrywide TB programme DQA demonstrate substantial undernotification and underreporting of TB cases across all provinces. This underscores the urgent need to impleme...

A Quality Assessment of the ARM-Net Registry Design and Data Collection.

Registries are important in rare disease research. The Anorectal Malformation Network (ARM-Net) registry is a well-established European patient registry collecting demographic, clinical, and functiona... Design and data elements were assessed for completeness, consistency, usefulness, accuracy, validity, and comparability. An intra- and inter-user variability study was conducted through monitoring and... We evaluated 119 data elements, of which 107 were utilized and comprised 42 string and 65 numeric elements. A minority (37.0%) of the 2278 included records had complete data, though this improved to 8... The ARM-Net registry presents one of the largest ARM cohorts. Although its collected data are valuable, they are susceptible to error and user variability. Continuous evaluations are required to maint... V....

Comparison of Data-Dependent Acquisition, Data-Independent Acquisition, and Parallel Reaction Monitoring in Trapped Ion Mobility Spectrometry-Time-of-Flight Tandem Mass Spectrometry-Based Lipidomics.

The parallel accumulation-serial fragmentation (PASEF) approach based on trapped ion mobility spectrometry (TIMS) enables mobility-resolved fragmentation and a higher number of fragments in the same t...

Smoking data quality of primary care practices in comparison with smoking data from the New Zealand Māori and Pacific abdominal aortic aneurysm screening programme: an observational study.

Quality smoking data is crucial for assessing smoking-related health risk and eligibility for interventions related to that risk. Smoking information collected in primary care practices (PCPs) is a ma... A two stage review was conducted. In Stage 1, data quality was assessed by comparing the PCP smoking data recorded close to AAA screening episodes with the data collected from participants at the AAA ... Of the 1841 people who underwent AAA screening, 1716 (93%) had PCP smoking information. Stage 1 PCP smoking data showed 82% concordance with the AAA data (adjusted kappa 0.76). Fewer current or ex-smo... PCP smoking data quality compared with the AAA data is consistent with international findings. PCP data captured fewer current and ex-smokers, suggesting ongoing improvement is important. Intervention...